Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3440)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2022 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol 2022; 14(2): 411-419 [PMID: 35317183 DOI: 10.4254/wjh.v14.i2.411] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i2/411.htm |
| Number | Citing Articles |
| 1 |
Shruti Sakhuja, Heather M. Staples, Charles G. Minard, Louise E. Ramm, Peter J. Lewindon, Grant A. Ramm, Daniel H. Leung. Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis‐related liver disease: A multi‐center study validated by liver biopsy. Liver International 2023; 43(6): 1277 doi: 10.1111/liv.15572
|
| 2 |
Zachary M. Sellers, David N. Assis, Shruti M. Paranjape, Meghana Sathe, Frank Bodewes, Melissa Bowen, Marco Cipolli, Dominique Debray, Nicole Green, Kara S. Hughan, William R. Hunt, Julio Leey, Simon C. Ling, Giuseppe Morelli, Daniel Peckham, Rebeca S. Pettit, Alexander Philbrick, Janis Stoll, Kay Vavrina, Stacy Allen, Tara Goodwin, Sarah E. Hempstead, Michael R. Narkewicz. Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology 2024; 79(5): 1220 doi: 10.1097/HEP.0000000000000646
|
| 3 |
Richard D. Maradiaga, Mitchell L. Ramsey, Stephen E. Kirkby, Lindsay A. Sobotka. The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators After Liver Transplantation in Persons With Cystic Fibrosis. ACG Case Reports Journal 2024; 11(1): e01261 doi: 10.14309/crj.0000000000001261
|
| 4 |
Sankalp Malhotra, J. Madison Hyer, Djhenne Dalmacy, Don Hayes, Dmitry Tumin, Stephen E Kirkby, Daniel E Jonas, Seuli Bose-Brill, Susan S. Li. Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population. Journal of Cystic Fibrosis 2024; doi: 10.1016/j.jcf.2023.11.013
|
| 5 |
Nathan Lieu, Bernadette J. Prentice, Penelope Field, Dominic A. Fitzgerald. Trials and tribulations of highly effective modulator therapies in cystic fibrosis. Paediatric Respiratory Reviews 2023; 48: 10 doi: 10.1016/j.prrv.2023.09.001
|
| 6 |
Anatasiya E. Krasnovidova, Olga I. Simonova, Vera P. Chernevich, Aleksandr V. Pakhomov, Aleksandra P. Reykh, Aleksandr A. Pushkov. Genotype-phenotype correlation in siblings with cystic fibrosis. Russian Pediatric Journal 2023; 26(3): 159 doi: 10.46563/1560-9561-2023-26-3-159-167
|